Number of Patients in Whom Tumor Was Resectable Up to 5 Years or Until Disease Progression [clinicaltrials_resource:8b0a7a406f28bce55104047776c5afaf]

Tumor response is measured in terms of resectability, as measured by CT scan at 2 weeks after completion of each course. A CT scan of the chest abdomen and pelvis will be performed in order to evaluate for the presence of metastatic disease. If no metastatic disease, emphasis will be paid to the local tumor. Evaluation of the growth/regression of the tumor will be made as it relates to resectability. If potential for resection then surgery will be recommended. This protocol will be followed after each cycle.

Number of Patients in Whom Tumor Was Resectable Up to 5 Years or Until Disease Progression [clinicaltrials_resource:8b0a7a406f28bce55104047776c5afaf]

Tumor response is measured in terms of resectability, as measured by CT scan at 2 weeks after completion of each course. A CT scan of the chest abdomen and pelvis will be performed in order to evaluate for the presence of metastatic disease. If no metastatic disease, emphasis will be paid to the local tumor. Evaluation of the growth/regression of the tumor will be made as it relates to resectability. If potential for resection then surgery will be recommended. This protocol will be followed after each cycle.